These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35771147)

  • 21. IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma.
    Liu C; Zhang W; Zhou X; Liu L
    Front Immunol; 2022; 13():983490. PubMed ID: 36618420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular phenotypic linkage between N
    Zhang F; Bi J; Liao J; Zhong W; Yu M; Lu X; Che J; Chen Z; Xu H; Hu S; Liu Y; Guo S
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):6901-6916. PubMed ID: 36826593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy.
    Qu J; Sun F; Hou Y; Qi H; Sun X; Xing L
    BMC Cancer; 2023 Jun; 23(1):549. PubMed ID: 37322434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma.
    Sun L; Liu Z; Wu Z; Ning K; Hu J; Chen Z; Wu Z; Yin X
    Front Immunol; 2023; 14():1113455. PubMed ID: 37051238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of TBC1D10B as a potential prognostic and immunotherapy relevant biomarker in liver hepatocellular carcinoma.
    Fan L; Tang Y; Li J; Huang W
    Sci Rep; 2023 Jan; 13(1):335. PubMed ID: 36611046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
    Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
    Front Immunol; 2021; 12():769425. PubMed ID: 34804059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy.
    Erstad DJ; Fuchs BC; Tanabe KK
    Cancer; 2018 Aug; 124(15):3084-3104. PubMed ID: 29663340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
    Yang Y; Xiao W; Liu R; Gao L; Chen J; Kan H
    J Immunol Res; 2022; 2022():4983532. PubMed ID: 36405011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma.
    Yu X; Chen P; Yi W; Ruan W; Xiong X
    Front Immunol; 2022; 13():1029872. PubMed ID: 36275676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
    Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
    Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in glioma.
    Luo H; Ye M; Hu Y; Wu M; Cheng M; Zhu X; Huang K
    Aging (Albany NY); 2022 Sep; 14(19):7824-7850. PubMed ID: 36152044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
    Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
    J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma.
    Zhang J; Gao J; Hu M; Xu S; Cheng C; Zheng W; Zhang J
    Eur J Med Res; 2023 Jan; 28(1):46. PubMed ID: 36707911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. m
    Li W; Liu J; Ma Z; Zhai X; Cheng B; Zhao H
    Dis Markers; 2021; 2021():8859590. PubMed ID: 34234878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation regulator-mediated modification pattern defines tumor microenvironment immune infiltration landscape in colon cancer.
    Yuan S; Gao Y; Xia Y; Wang Z; Wang X
    Front Genet; 2022; 13():1008644. PubMed ID: 36276973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA5mC Regulator-Mediated Molecular Clusters and Tumor Microenvironment Signatures in Glioblastoma.
    Yu X; Che Y; Li W; Zhang P; Yu Y; Chen J; Gong T; Cao F
    Front Cell Dev Biol; 2022; 10():1055567. PubMed ID: 36425533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma.
    Tang Y; Guo C; Yang Z; Wang Y; Zhang Y; Wang D
    Front Immunol; 2022; 13():862527. PubMed ID: 35493471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.